Invesco Ltd. Nkarta, Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.31 - $6.6 $264,295 - $1.33 Million	201,752 New	201,752 $1.33 Million
Q4 2022 Feb 13, 2023	BUY	$5.14 - $14.35 $60,795 - $169,731	11,828 New	11,828 $70,000
Q1 2021 May 17, 2021	SELL	$31.33 - $59.61 $110,281 - $209,827	-3,520 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.03 - $75.62 $95,145 - $266,182	3,520 New	3,520 $217,000

127

66.6M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $114M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.